IRIS Accounts Production v25.2.0.378 04163487 Board of Directors 1.5.24 30.4.25 30.4.25 false true false false true false Ordinary shares 1.00000 iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 04163487 2024-04-30 04163487 2025-04-30 04163487 2024-05-01 2025-04-30 04163487 2023-04-30 04163487 2023-05-01 2024-04-30 04163487 2024-04-30 04163487 ns15:EnglandWales 2024-05-01 2025-04-30 04163487 ns14:PoundSterling 2024-05-01 2025-04-30 04163487 ns10:Director1 2024-05-01 2025-04-30 04163487 ns10:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 04163487 ns10:SmallEntities 2024-05-01 2025-04-30 04163487 ns10:AuditExempt-NoAccountantsReport 2024-05-01 2025-04-30 04163487 ns10:SmallCompaniesRegimeForDirectorsReport 2024-05-01 2025-04-30 04163487 ns10:SmallCompaniesRegimeForAccounts 2024-05-01 2025-04-30 04163487 ns10:FullAccounts 2024-05-01 2025-04-30 04163487 ns10:OrdinaryShareClass1 2024-05-01 2025-04-30 04163487 ns10:Director2 2024-05-01 2025-04-30 04163487 ns10:CompanySecretary1 2024-05-01 2025-04-30 04163487 ns10:RegisteredOffice 2024-05-01 2025-04-30 04163487 ns5:CurrentFinancialInstruments 2025-04-30 04163487 ns5:CurrentFinancialInstruments 2024-04-30 04163487 ns5:Non-currentFinancialInstruments 2025-04-30 04163487 ns5:Non-currentFinancialInstruments 2024-04-30 04163487 ns5:ShareCapital 2025-04-30 04163487 ns5:ShareCapital 2024-04-30 04163487 ns5:RetainedEarningsAccumulatedLosses 2025-04-30 04163487 ns5:RetainedEarningsAccumulatedLosses 2024-04-30 04163487 ns5:PlantMachinery 2024-05-01 2025-04-30 04163487 ns5:LandBuildings 2024-04-30 04163487 ns5:PlantMachinery 2024-04-30 04163487 ns5:LandBuildings 2024-05-01 2025-04-30 04163487 ns5:LandBuildings 2025-04-30 04163487 ns5:PlantMachinery 2025-04-30 04163487 ns5:LandBuildings 2024-04-30 04163487 ns5:PlantMachinery 2024-04-30 04163487 ns5:LeasedAssetsHeldAsLessee ns5:PlantMachinery 2024-05-01 2025-04-30 04163487 ns5:LeasedAssetsHeldAsLessee ns5:PlantMachinery 2025-04-30 04163487 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-04-30 04163487 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-04-30 04163487 ns10:OrdinaryShareClass1 2025-04-30

REGISTERED NUMBER: 04163487 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30TH APRIL 2025

FOR

HODGSON PHARMACY LIMITED

HODGSON PHARMACY LIMITED (REGISTERED NUMBER: 04163487)

CONTENTS OF THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30TH APRIL 2025

Page |

Company Information | 1 |

Balance Sheet | 2 |

Notes to the Financial Statements | 3 |

HODGSON PHARMACY LIMITED

COMPANY INFORMATION

FOR THE YEAR ENDED 30TH APRIL 2025

| DIRECTORS: | Mr D C Patel

| Mr A D Patel

| SECRETARY: | Mr D C Patel

| REGISTERED OFFICE: | 59 Station Road

| Longfield

| Kent

| DA3 7QA

| REGISTERED NUMBER: | 04163487 (England and Wales)

| BANKERS: | National Westminster Bank plc

| 12 High Street

| Dartford

| Kent

| DA1 1DD

HODGSON PHARMACY LIMITED (REGISTERED NUMBER: 04163487)

BALANCE SHEET

30TH APRIL 2025

| 2025 | 2024 |

| Notes | £ | £ | £ | £ |

FIXED ASSETS

Tangible assets | 4 | 199,836 |  | 127,288 |  |

CURRENT ASSETS

Stocks | 98,381 |  | 83,708 |  |

Debtors | 5 | 74,053 |  | 35,970 |  |

Cash at bank and in hand | 347,327 |  | 324,584 |  |

519,761 |  | 444,262 |  |

CREDITORS

Amounts falling due within one year | 6 | 302,534 |  | 324,128 |  |

NET CURRENT ASSETS | 217,227 |  | 120,134 |  |

TOTAL ASSETS LESS CURRENT LIABILITIES | 417,063 |  | 247,422 |  |

CREDITORS

Amounts falling due after more than one year | 7 | (79,089 | ) | - |  |

PROVISIONS FOR LIABILITIES | (47,000 | ) | (47,000 | ) |

NET ASSETS | 290,974 |  | 200,422 |  |

CAPITAL AND RESERVES

Called up share capital | 8 | 20,000 |  | 20,000 |  |

Retained earnings | 270,974 |  | 180,422 |  |

SHAREHOLDERS' FUNDS | 290,974 |  | 200,422 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30th April 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30th April 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 3rd October 2025 and were signed on its behalf by:

Mr D C Patel - Director

HODGSON PHARMACY LIMITED (REGISTERED NUMBER: 04163487)

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30TH APRIL 2025

1. | STATUTORY INFORMATION

| Hodgson Pharmacy Limited is a private company, limited by shares, registered in England and Wales. The company's registered number is 04163487 and registered office address is 59 Station Road, Longfield, Kent, DA3 7QA.

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Turnover

| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

| Tangible fixed assets

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.

| Plant and machinery etc | - | 15% on reducing balance

| Stocks

| Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

| Hire purchase and leasing commitments

| Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

| The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

| Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

| Pension costs and other post-retirement benefits

| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was 13 (2024 - 10 ) .

HODGSON PHARMACY LIMITED (REGISTERED NUMBER: 04163487)

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 30TH APRIL 2025

4. | TANGIBLE FIXED ASSETS

| Plant and |

| Land and |  | machinery |

| buildings |  | etc |  | Totals

£ | £ | £ |

| COST

| At 1st May 2024 | 29,286 |  | 520,283 |  | 549,569 |  |

| Additions | - |  | 123,751 |  | 123,751 |  |

| At 30th April 2025 | 29,286 |  | 644,034 |  | 673,320 |  |

| DEPRECIATION

| At 1st May 2024 | 24,467 |  | 397,814 |  | 422,281 |  |

| Charge for year | 723 |  | 50,480 |  | 51,203 |  |

| At 30th April 2025 | 25,190 |  | 448,294 |  | 473,484 |  |

| NET BOOK VALUE

| At 30th April 2025 | 4,096 |  | 195,740 |  | 199,836 |  |

| At 30th April 2024 | 4,819 |  | 122,469 |  | 127,288 |  |

| Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

| Plant and

| machinery

| etc

£ |

| COST

| Additions | 112,776 |  |

| At 30th April 2025 | 112,776 |  |

| DEPRECIATION

| Charge for year | 28,193 |  |

| At 30th April 2025 | 28,193 |  |

| NET BOOK VALUE

| At 30th April 2025 | 84,583 |  |

5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2025 | 2024 |

£ | £ |

| Trade debtors | 45,785 |  | 8,052 |  |

| Other debtors | 28,268 |  | 27,918 |  |

74,053 |  | 35,970 |  |

HODGSON PHARMACY LIMITED (REGISTERED NUMBER: 04163487)

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 30TH APRIL 2025

6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2025 | 2024 |

£ | £ |

| Hire purchase contracts | 14,668 |  | - |  |

| Trade creditors | 236,893 |  | 228,092 |  |

| Taxation and social security | 22,541 |  | 30,159 |  |

| Other creditors | 28,432 |  | 65,877 |  |

302,534 |  | 324,128 |  |

7. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |

2025 | 2024 |

£ | £ |

| Hire purchase contracts | 79,089 |  | - |  |

8. | CALLED UP SHARE CAPITAL

| Allotted, issued and fully paid:

| Number: | Class: | Nominal | 2025 | 2024 |

| value: | £ | £ |

| 20,000 | Ordinary shares | £1 | 20,000 |  | 20,000 |  |

9. | RELATED PARTY DISCLOSURES

| The company paid £12,000 (2024: £12,000) as rent to Mr D.C. Patel. An amount of £1,695 (2024: £41,695 ) was due to Mr D C Patel at the year end.

10. | ULTIMATE CONTROLLING PARTY

| The company was under the control of the director and majority shareholder, Mr D.C. Patel throughout the current year and previous period.